GCSH Human

Glycine Cleavage System Protein H Human Recombinant
Cat. No.
BT11419
Source
E.coli.
Synonyms
Glycine cleavage system protein H (aminomethyl carrier), NKH, GCE, Lipoic acid-containing protein, Mitochondrial glycine cleavage system H-protein.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

GCSH Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 149 amino acids (48-173) and having a molecular mass of 16.4 kDa.
GCSH is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
The glycine cleavage system, responsible for glycine breakdown, comprises four mitochondrial proteins: P, H, T, and L proteins. GCSH, the H protein, facilitates the transfer of the methylamine group from glycine bound to the P protein to the T protein. Genetic mutations affecting the GCSH gene can lead to nonketotic hyperglycinemia (NKH).
Description
Recombinant GCSH, produced in E.coli, is a single, non-glycosylated polypeptide chain consisting of 149 amino acids (residues 48-173) and possessing a molecular weight of 16.4 kDa. This protein is engineered with a 24 amino acid His-tag fused to its N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The provided GCSH solution (concentration: 1mg/ml) is formulated in a buffer containing 20mM Tris-HCl (pH 8.0), 1mM DTT, 0.15M NaCl, and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advisable for long-term storage. Repeated freeze-thaw cycles should be avoided.
Purity
The purity of the GCSH protein is determined to be greater than 95% based on SDS-PAGE analysis.
Synonyms
Glycine cleavage system protein H (aminomethyl carrier), NKH, GCE, Lipoic acid-containing protein, Mitochondrial glycine cleavage system H-protein.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSVRKFT EKHEWVTTEN GIGTVGISNF AQEALGDVVY CSLPEVGTKL NKQDEFGALE SVKAASELYS PLSGEVTEIN EALAENPGLV NKSCYEDGWL IKMTLSNPSE LDELMSEEAY EKYIKSIEE

Product Science Overview

Introduction

Glycine Cleavage System Protein H (GCSH) is a crucial component of the glycine cleavage system (GCS), a highly conserved protein complex responsible for the oxidative cleavage of glycine. This system is essential for glycine catabolism, which involves the release of carbon dioxide (CO₂) and ammonia (NH₃), and the transfer of a methylene group to tetrahydrofolate, with the concomitant reduction of NAD⁺ to NADH .

Structure and Function

The glycine cleavage system consists of four main proteins: glycine decarboxylase (GLDC), aminomethyltransferase (AMT), dehydrolipamide dehydrogenase (DLD), and the H-protein (GCSH). The H-protein acts as a shuttle, interacting with the other three proteins via a lipoyl swinging arm . This interaction is crucial for the proper functioning of the GCS, enabling the decarboxylation of glycine and the subsequent metabolic processes.

Role in Metabolism

GCSH is located at the mitochondrial membrane in eukaryotes and plays a significant role in the major route of glycine catabolism. The glycine cleavage system is part of the most prominent glycine and serine catabolism pathway in humans and most vertebrates . This pathway is vital for the formation of 5,10-methylenetetrahydrofolate, a crucial C₁ donor in biosynthesis .

Genetic Implications

Mutations in the genes encoding the components of the glycine cleavage system, such as AMT or GLDC, can lead to severe metabolic disorders. These include neural tube defects (NTDs) and ventriculomegaly, as well as a post-natal life-limiting neurometabolic disorder known as Non-Ketotic Hyperglycinemia . However, the specific role of GCSH mutations in these conditions is less clear. Studies have shown that loss of function in GCSH can cause embryonic death prior to mid-gestation, indicating its essential role in embryonic development .

Additional Functions

Recent research suggests that GCSH may have additional roles beyond its function in the glycine cleavage system. It is hypothesized that GCSH may act in the lipoylation of 2-oxoacid dehydrogenase proteins, a function reported in bacteria . This potential additional role highlights the importance of GCSH in various metabolic processes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.